Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: £9.18 Billion

As of October 2024 Neurocrine Biosciences has a market cap of £9.18 Billion. This makes Neurocrine Biosciences the world's 1485th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 17th, 2024 the market cap of Neurocrine Biosciences was reported to be:

£9.18 Billion

by Yahoo Finance

£9.18 Billion

by CompaniesMarketCap

£9.18 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Repligen RGEN	£6.11 B	-33.45%	🇺🇸 USA
Royalty Pharma RPRX	£12.78 B	39.17%	🇬🇧 UK
Palatin Technologies PTN	£15.01 M	-99.84%	🇺🇸 USA
Eli Lilly LLY	£634.19 B	6,803.74%	🇺🇸 USA
AbbVie ABBV	£255.79 B	2,684.56%	🇺🇸 USA
Pfizer PFE	£127.38 B	1,286.64%	🇺🇸 USA
ANI Pharmaceuticals ANIP	£0.97 B	-89.43%	🇺🇸 USA
Athersys ATHX	£0.63 M	-99.99%	🇺🇸 USA